{"id":"NCT04642079","sponsor":"Pfizer","briefTitle":"Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age","officialTitle":"A PHASE 3, SINGLE-ARM TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY CHILDREN 15 MONTHS THROUGH 17 YEARS OF AGE","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-12-04","primaryCompletion":"2022-04-06","completion":"2022-04-06","firstPosted":"2020-11-24","resultsPosted":"2023-04-26","lastUpdate":"2024-01-22"},"enrollment":839,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"20vPnC","otherNames":[]}],"arms":[{"label":"Cohort 1: =>15 through 23 months of age","type":"EXPERIMENTAL"},{"label":"Cohort 2: 2 through 4 years of age","type":"EXPERIMENTAL"},{"label":"Cohort 3: 5 through 9 years of age","type":"EXPERIMENTAL"},{"label":"Cohort 4: 10 through 17 years of age","type":"EXPERIMENTAL"}],"summary":"This study is designed to evaluate the safety and immunogenicity of 20vPnC in healthy children 15 months through 17 years of age","primaryOutcome":{"measure":"Percentage of Participants Reporting Prompted Local Reactions Within 7 Days After Vaccination","timeFrame":"Within 7 days after vaccination on Day 1","effectByArm":[{"arm":"Cohort 1: 20vPnC: >=15 to <24 Months","deltaMin":37.7,"sd":null},{"arm":"Cohort 2: 20vPnC: >=2 to <5 Years","deltaMin":39.1,"sd":null},{"arm":"Cohort 3: 20vPnC: >=5 to <10 Years","deltaMin":37.2,"sd":null},{"arm":"Cohort 4: 20vPnC: >=10 to <18 Years","deltaMin":15.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":43,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B7471014"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":209},"commonTop":["Injection site pain (PAIN)","Injection site erythema (REDNESS)","Myalgia (MUSCLE PAIN)","Fatigue (FATIGUE)","Injection site swelling (SWELLING)"]}}